The number of reports of problems related to synthetic benzodiazepines, molecules used as drugs and with particularly marked effects, is up, said the National Agency for Medicines (ANSM), evoking the identification of new molecules on Thursday.
“The number of addictovigilance reports linked to the benzodiazepines of synthesis continues to increase and new molecules of this class have been identified in the territory,” the ANSM summed up in a press release.
These molecules, with the structure close to conventional benzodiazepines but modified in order to accentuate their effects, are sold on the Internet and used “to reduce anxiety, as a sedative or in combination with other drugs”.
Serious health effects
However “the power of action of these synthetic benzodiazepines means that they can cause serious effects for health, even at very low dose: severe sedation – drowsiness to coma -, confusion, agitation, alteration of memory, balance and coordination disorders, difficulties in breathing”, continues the ANSM.
“These side effects can last several days,” they insist. “The risk of overdose – overdose – potentially fatal is also very high. »»
These products are theoretically prohibited. But new molecules have appeared, in fact escaping the regulations because they did not appear on the list of psychotropic drugs established by the ANSM.
She therefore spotted nine new molecules that she will write on this list. Their production, sale and consumption will therefore be explicitly prohibited from this Thursday.
These are the Bentazépam, Bromonordiazepam – Synonym Disalkylgidazépam -, Fluclotizolam, Fluclotizolam, MethylClonazepam, Norflurazepam – Synoflurazepam – Synonym Norfludiazépam or Disalkylfumépam – Synonym Demethylsulazepam-, and Tofisopam – Synonym Emandaxin.